HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hartmut Porst Selected Research

Tadalafil (Cialis)

1/2016Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
11/2015Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities.
2/2014Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
9/2013Efficacy and safety of tadalafil 5 mg once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: subgroup analyses of pooled data from 4 multinational, randomized, placebo-controlled clinical studies.
8/2013Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
11/2012Effects of once-daily tadalafil on treatment satisfaction, psychosocial outcomes, spontaneous erections, and measures of endothelial function in men with erectile dysfunction but naive to phosphodiesterase type 5 inhibitors.
7/2012Chronic PDE-5 inhibition in patients with erectile dysfunction - a treatment approach using tadalafil once-daily.
5/2012A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction.
11/2011Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.
9/2011A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hartmut Porst Research Topics

Disease

36Erectile Dysfunction
01/2021 - 03/2003
9Lower Urinary Tract Symptoms
02/2017 - 06/2008
9Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2016 - 06/2008
7Headache (Headaches)
11/2012 - 07/2003
6Premature Ejaculation
07/2019 - 06/2010
4Hypogonadism (Hypergonadotropic Hypogonadism)
07/2019 - 01/2013
4Hypertension (High Blood Pressure)
02/2014 - 11/2006
3Back Pain (Backache)
11/2012 - 09/2011
3Dyspepsia (Indigestion)
11/2012 - 07/2003
3Flushing
10/2005 - 07/2003
2Penile Induration (Peyronie's Disease)
01/2021 - 01/2019
2Hyperlipidemias (Hyperlipidemia)
02/2014 - 11/2006
2Weight Loss (Weight Reduction)
01/2013 - 10/2010
2Myalgia
09/2011 - 07/2003
1Hyperprolactinemia
07/2019
1Prostatic Neoplasms (Prostate Cancer)
02/2017
1Heart Diseases (Heart Disease)
02/2014
1Ganglion Cysts (Ganglion)
01/2014
1Cardiovascular Diseases (Cardiovascular Disease)
09/2013
1Dyslipidemias (Dyslipidemia)
01/2013
1Atherosclerosis
10/2011
1Ejaculatory Dysfunction
10/2011
1Nasopharyngitis
09/2011
1Psychomotor Agitation (Akathisia)
02/2011
1Nausea
02/2011
1Dizziness (Lightheadedness)
02/2011
1Chronic Disease (Chronic Diseases)
08/2006

Drug/Important Bio-Agent (IBA)

18Phosphodiesterase 5 InhibitorsIBA
07/2019 - 09/2004
17Tadalafil (Cialis)FDA Link
01/2016 - 07/2003
10Vardenafil Dihydrochloride (Levitra)FDA Link
07/2008 - 09/2003
8Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
09/2013 - 03/2003
5Testosterone (Sustanon)FDA Link
02/2017 - 01/2011
4dapoxetineIBA
07/2019 - 06/2010
4Sildenafil Citrate (Viagra)FDA Link
05/2012 - 03/2003
2Prilocaine Drug Combination LidocaineFDA LinkGeneric
07/2019 - 01/2019
1ProlactinIBA
07/2019
1propylene diquat (PDQ(+))IBA
01/2019
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2019
1Local AnestheticsIBA
01/2019
1Prostate-Specific Antigen (Semenogelase)IBA
02/2017
1N-acetyltryptophanamide (NATA)IBA
05/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2011
1Guanosine Monophosphate (5' Guanylic Acid)IBA
10/2011
1Adrenergic Agents (Adrenergic Drugs)IBA
10/2011
1rho-Associated KinasesIBA
10/2011
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
07/2003
1Therapeutic UsesIBA
07/2003
1Pharmaceutical PreparationsIBA
03/2003
1G-protein beta3 subunitIBA
03/2003

Therapy/Procedure

9Therapeutics
01/2019 - 08/2006
2Drug Therapy (Chemotherapy)
10/2011 - 09/2004
1Prostatectomy (Retropubic Prostatectomy)
01/2021
1Extracorporeal Shockwave Therapy
01/2021
1Conservative Treatment
06/2019
1Traction
01/2019
1Combination Drug Therapy (Combination Chemotherapy)
08/2013
1Withholding Treatment
10/2010